[
1. Ragusa F, Fallahi P, Elia G, Gonnella D, Paparo SR, Giusti C, et al. Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019 Dec;33(6):101367.10.1016/j.beem.2019.10136731812326
]Search in Google Scholar
[
2. Sviridenko NY, Bessmertnaya EG, Belovalova IM, Mikheenkov AA, Sheremeta MS, Nikankina LV, Malysheva NM. Autoantibodies, immunoglobulins and cytokine profile in patients with graves’ disease and Graves’ orbitopathy. Probl Endokrinol (Mosk). 2020;66 (5):15-2310.14341/probl1254433369369
]Search in Google Scholar
[
3. Degen A, Krynytska I, Kamyshnyi A. Changes in the transcriptional activity of the entero-insular axis genes in streptozotocin-induced diabetes and after the administration of TNF-α non-selective blockers. Endocrine Regulations. 2020; 54(3):160-171.10.2478/enr-2020-001932857721
]Search in Google Scholar
[
4. Kamyshna II, Pavlovych LB, Maslyanko VA, Kamyshnyi AM. Analysis of the transcriptional activity of genes of neuropeptides and their receptors in the blood of patients with thyroid pathology. J Med Life. 2021;14(2): 243-249.10.25122/jml-2020-0183816913734104248
]Search in Google Scholar
[
5. Bilous II, Korda MM, Krynytska IY, Kamyshnyi AM. Nerve impulse transmission pathway-focused genes expression analysis in patients with primary hypothyroidism and autoimmune thyroiditis. Endocr Regul. 2020;54(2):109-18.10.2478/enr-2020-001332597152
]Search in Google Scholar
[
6. Bilous I., Pavlovych L., Krynytska I., Marushchak M., Kamyshnyi A. Apoptosis and Cell Cycle Pathway-Focused Genes Expression Analysis in Patients with Different Forms of Thyroid Pathology. Open Access Macedonian Journal of Medical Sciences. 2020;8(B): 1-9.10.3889/oamjms.2020.4760
]Search in Google Scholar
[
7. Bilous I., Pavlovych L, Kamyshnyi A. Primary hypothyroidism and autoimmune thyroiditis alter the transcriptional activity of genes regulating neurogenesis in the blood of patients. Endocr Regul. 2021 Jan; 55(1):101–111.10.2478/enr-2021-000233600668
]Search in Google Scholar
[
8. Cheng CW, Wu CZ, Tang KT, Fang WF, Lin JD. Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases. Autoimmunity. 2020;53(5):261-269.10.1080/08916934.2020.175596532338082
]Search in Google Scholar
[
9. Fallahi P, Ferrari SM, Ragusa F, Ruffilli I, Elia G, Paparo SR, Antonelli A. Th1 Chemokines in Autoimmune Endocrine Disorders. J Clin Endocrinol Metab. 2020;105(4):dgz289.10.1210/clinem/dgz28931863667
]Search in Google Scholar
[
10. Martin TC, Ilieva KM, Visconti A, Beaumont M, Kiddle SJ, Dobson RJB, et al. Dysregulated Antibody, Natural Killer Cell and Immune Mediator Profiles in Autoimmune Thyroid Diseases. Cells. 2020;9(3):665.10.3390/cells9030665714064732182948
]Search in Google Scholar
[
11. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028.10.4158/EP12280.GL23246686
]Search in Google Scholar
[
12. Koval HD, Chopyak VV, Kamyshnyi OM, Kurpisz MK. Transcription regulatory factor expression in T-helper cell differentiation pathway in eutopic endometrial tissue samples of women with endometriosis associated with infertility. Cent Eur J Immunol. 2018;43(1):90-6.10.5114/ceji.2018.74878592717829736151
]Search in Google Scholar
[
13. Zherebiatiev A. Kamyshnyi A. Expression levels of proinflammatory cytokines and NLRP3 inflammasome in an experimental model of oxazolone-induced colitis. Iranian Journal of Allergy, Asthma and Immunology. 2016;15(1):39-45.
]Search in Google Scholar
[
14. Nosulenko IS, Voskoboynik OY, Berest GG, Safronyuk SL, Kovalenko SI, Kamyshnyi OM, Polishchuk NM, Sinyak RS, Katsev AV. Synthesis and Antimicrobial Activity of 6-Thioxo-6,7-dihydro-2H-[1,2,4]triazino[2, 3-c]-quinazolin-2-one Derivatives. Sci Pharm. 2014;82 (3):483-500.10.3797/scipharm.1402-10431815125853063
]Search in Google Scholar
[
15. Wu W, Ren F, Guo M, Yang J, Xiao Y, Liu W. Increased expression of CX3CL1 and CX3CR1 in papillary thyroid carcinoma. Histol Histopathol. 2020;35(10): 1189-1196.
]Search in Google Scholar
[
16. Lee M, Lee Y, Song J, Lee J, Chang SY. Tissue-specific Role of CX3CR1 Expressing Immune Cells and Their Relationships with Human Disease. Immune Netw. 2018 Feb;18(1):e5.10.4110/in.2018.18.e5583312429503738
]Search in Google Scholar
[
17. Hamon P, Loyher PL, Baudesson de Chanville C, Licata F, Combadiere C, Boissonnas A. CX3CR1-dependent endothelial margination modulates Ly6C(high) monocyte systemic deployment upon inflammation in mice. Blood. 2017 Mar 9;129(10):1296-307.10.1182/blood-2016-08-73216428011675
]Search in Google Scholar
[
18. Mousavi A. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targetedtherapy. Immunol Lett. 2020;217:91-115.10.1016/j.imlet.2019.11.00731747563
]Search in Google Scholar
[
19. García-Cuesta EM, Santiago CA, Vallejo-Díaz J, Juarranz Y, Rodríguez-Frade JM, Mellado M. The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases. Front Endocrinol (Lausanne). 2019 Aug 27;10:585.10.3389/fendo.2019.00585671845631507535
]Search in Google Scholar
[
20. Armengol MP, Cardoso-Schmidt CB, Fernandez M, Ferrer X, Pujol-Borrell R, Juan M. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J Immunol. 2003 Jun 15;170(12):6320-8.10.4049/jimmunol.170.12.632012794165
]Search in Google Scholar
[
21. Luty J, Ruckemann-Dziurdzińska K, Witkowski JM, Bryl E. Immunological aspects of autoimmune thyroid disease - Complex interplay between cells and cytokines. Cytokine. 2019;116:128-133.10.1016/j.cyto.2019.01.00330711852
]Search in Google Scholar
[
22. Xiong Z, Sun Y, Wu J, Niu F, Jin T, Li B. Genetic polymorphisms in IL1R1 and IL1R2 are associated with susceptibility to thyroid cancer in the Chinese Han population. J Gene Med. 2019;21(6):e3093.10.1002/jgm.309331021479
]Search in Google Scholar
[
23. Yan H, Hong Y, Cai Y. Association between FAS gene -670 A/G and -1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis. Biosci Rep. 2020;40(1): BSR20191197.10.1042/BSR20191197694465731840751
]Search in Google Scholar
[
24. Sun L, Zhang X, Dai F, Shen J, Ren C, Zuo C, et al. Elevated interleukin-1beta in peripheral blood mononuclear cells contributes to the pathogenesis of autoimmune thyroid diseases, especially of Hashimoto thyroiditis. Endocr Res. 2016;41(3):185-92.10.3109/07435800.2015.112443926864865
]Search in Google Scholar
[
25. Kristensen B, Hegedus L, Lundy SK, Brimnes MK, Smith TJ, Nielsen CH. Characterization of Regulatory B Cells in Graves’ Disease and Hashimoto’s Thyroiditis. PLoS One. 2015;10(5):e0127949.10.1371/journal.pone.0127949444633526016954
]Search in Google Scholar
[
26. Gerenova J, Stanilova S. IL-12B and IL-10 gene polymorphisms in the development of Hashimoto’s thyroiditis. Int J Immunogenet. 2016;43(6):397-403.10.1111/iji.1229327774749
]Search in Google Scholar
[
27. Inoue N, Watanabe M, Wada M, Morita M, Hidaka Y, Iwatani Y. IL-10-592A/C polymorphism is associated with severity of Hashimoto’s disease. Cytokine. 2013;64(1):370-4.10.1016/j.cyto.2013.05.01423757290
]Search in Google Scholar
[
28. Kagawa T, Watanabe M, Inoue N, Otsu H, Saeki M, Katsumata Y, et al. Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto’s disease. Endocr J. 2016 Apr 25;63(4):375-80.10.1507/endocrj.EJ15-057726821743
]Search in Google Scholar
[
29. Stożek K, Grubczak K, Marolda V, Eljaszewicz A, Moniuszko M, Bossowski A. Lower proportion of CD19+IL-10+ and CD19+CD24+CD27+ but not CD1d+CD5+CD19+CD24+CD27+ IL-10+ B cells in children with autoimmune thyroid diseases. Autoimmunity. 2020;53(1):46-55.10.1080/08916934.2019.169769031790305
]Search in Google Scholar
[
30. Huang H, Fang M, Jostins L, Umicevic Mirkov M, Boucher G, Anderson CA, et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature. 2017;547(7662):173-8.10.1038/nature22969551151028658209
]Search in Google Scholar
[
31. Zhang GQ, Jiao Q, Shen CT, Song HJ, Zhang HZ, Qiu ZL, Luo QY. Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer. Cancer Sci. 2021;112(3):997-1010.10.1111/cas.14752793580033247999
]Search in Google Scholar
[
32. Kaur S, Bansal Y, Kumar R, Bansal G. A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors. Bioorg Med Chem. 2020;28(5):115327.10.1016/j.bmc.2020.11532731992476
]Search in Google Scholar
[
33. Kristensen B. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls. Dan Med J. 2016 Feb;63(2):B5177.
]Search in Google Scholar
[
34. Sieminska L, Wojciechowska C, Kos-Kudla B, Marek B, Kajdaniuk D, Nowak M, et al. Serum concentrations of leptin, adiponectin, and interleukin-6 in postmenopausal women with Hashimoto’s thyroiditis. Endokrynol Pol. 2010;61(1):112-6.
]Search in Google Scholar
[
35. Ferreira RC, Freitag DF, Cutler AJ, Howson JM, Rainbow DB, Smyth DJ, et al. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet. 2013;9(4):e1003444.10.1371/journal.pgen.1003444361709423593036
]Search in Google Scholar
[
36. Ferrari SM, Fallahi P, Elia G, Ragusa F, Camastra S, Paparo SR, Giusti C, Gonnella D, Ruffilli I, Shoenfeld Y, Antonelli A. Novel therapies for thyroid autoimmune diseases: An update. Best Pract Res Clin Endocrinol Metab. 2020;34(1):101366.10.1016/j.beem.2019.10136631813786
]Search in Google Scholar
[
37. Marinou I, Healy J, Mewar D, Moore DJ, Dickson MC, Binks MH, et al. Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Arthritis Rheum. 2007;56(8):2549-56.10.1002/art.22814243541617665434
]Search in Google Scholar
[
38. Davis SM, Collier LA, Leonardo CC, Seifert HA, Ajmo CT, Jr., Pennypacker KR. Leukemia Inhibitory Factor Protects Neurons from Ischemic Damage via Upregulation of Superoxide Dismutase 3. Mol Neurobiol. 2017;54(1):608-22.10.1007/s12035-015-9587-2502663326746670
]Search in Google Scholar
[
39. Davis SM, Collier LA, Goodwin S, Lukins DE, Powell DK, Pennypacker KR. Efficacy of leukemia inhibitory factor as a therapeutic for permanent large vessel stroke differs among aged male and female rats. Brain Res. 2019;1707:62-73.10.1016/j.brainres.2018.11.017681430430445025
]Search in Google Scholar
[
40. Ren SG, Seliktar J, Li X, Hershman JM, Braunstein GD, Melmed S. In vivo and in vitro regulation of thyroid leukemia inhibitory factor (LIF): marker of hypothyroidism. J Clin Endocrinol Metab. 1999;84(8):2883-7.10.1210/jc.84.8.2883
]Search in Google Scholar
[
41. Aghajanova L, Stavreus-Evers A, Lindeberg M, Landgren BM, Sparre LS, Hovatta O. Thyroid-stimulating hormone receptor and thyroid hormone receptors are involved in human endometrial physiology. Fertil Steril. 2011;95(1):230-7.10.1016/j.fertnstert.2010.06.07920691434
]Search in Google Scholar
[
42. Shan L, Zhou Y, Peng S, Wang X, Shan Z, Teng W. Implantation failure in rats with subclinical hypothyroidism is associated with LIF/STAT3 signaling. Endocr Connect. 2019;8(6):718-27.10.1530/EC-19-0185654730731063977
]Search in Google Scholar
